Tue. 18 Jun 2024, 4:09am ET
Benzinga
News
- Advanz Pharma secures rights to commercialize Alvotech's biosimilar candidate for Eylea® in Europe
- Advanz Pharma will leverage its existing specialty and hospital capabilities in Europe to ensure successful market registration, commercialization, and patient access